Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cypress Bioscience: Investing in Pain
Seeking Alpha
Tuesday, May 12, 2009 - 7:11am
tags:
Cypress Bioscience, fibromyalgia
Icahn Suggests Biogen Split Cancer, Neurology Lines
Bloomberg
Tuesday, May 12, 2009 - 7:10am
tags:
Carl Icahn, Biogen Idec, neurology, oncology
Merck Wins Extension to Appeal Vioxx Certification in Ontario
Bloomberg
Tuesday, May 12, 2009 - 7:09am
tags:
Merck, Canada, Vioxx
Swine flu vaccine manufacturers gear up
FT.com
Monday, May 11, 2009 - 7:22pm
tags:
swine flu, vaccines, MedImmune, Solvay, Baxter International, GSK, Novartis, CSL
Valeant Over 200-day Moving Average
Yahoo/Zacks.com
Monday, May 11, 2009 - 7:19pm
tags:
Valeant Pharmaceuticals
Vanda, Up 800%, Still Has Room to Rise
TheStreet.com
Monday, May 11, 2009 - 7:18pm
tags:
Vanda, Fanapt
Danish drug maker Novo Nordisk agrees to pay $9M in oil-for-food kickback scheme with Saddam
Yahoo/AP
Monday, May 11, 2009 - 4:08pm
tags:
Novo Nordisk
Warner Chilcott 1Q profit jumps 29 percent
Yahoo/AP
Monday, May 11, 2009 - 4:07pm
tags:
Warner Chilcott, earnings
Merck and Elsevier Cross the Line in Joint Medical 'Journal'
Seeking Alpha
Monday, May 11, 2009 - 4:07pm
tags:
Merck, Elsevier
Celera Retains Sell Rating
Yahoo/Zacks.com
Monday, May 11, 2009 - 4:06pm
tags:
Celera, Abbott Laboratories, earnings
Biotech Rocket Stocks for the Week
TheStreet.com
Monday, May 11, 2009 - 2:14pm
tags:
biotech, Biocryst, Novavax, Pfizer, JNJ, Vanda, Cell Therapeutics, OSI Pharmaceuticals
Two Delaware Deaths Prompt Review of Baxter's Heparin
WSJ Online
Monday, May 11, 2009 - 2:13pm
tags:
Delaware, Heparin, Baxter International
Rx for flu: statins?
CNN Money/Fortune
Monday, May 11, 2009 - 2:12pm
tags:
Flu, statins, swine flu
Targacept shares gain ground as drug passes midstage clinical trial, 1st-quarter loss narrows
Yahoo/AP
Monday, May 11, 2009 - 2:11pm
tags:
Targacept, drug trials, earnings, ADHD
Anger over GSK's bonus for ex-boss
The Guardian, UK
Monday, May 11, 2009 - 2:10pm
tags:
GSK, Pharma CEOs
Top 15 Big Pharma Paychecks of 2008
Fierce Pharma
Monday, May 11, 2009 - 11:04am
tags:
Big Pharma, Pharma CEOs
Amarin wins FDA agreement on Phase III cardiovascular trial
Pharmaceutical Business Review
Monday, May 11, 2009 - 11:04am
tags:
Amarin, FDA
Tuesday: House Energy & Commerce Committee to hold hearing on medical devices
Energy and Commerce Committee
Monday, May 11, 2009 - 10:49am
tags:
medical devices
Vanda's Iloperidone: Not Something You See Every Day
InVivo
Monday, May 11, 2009 - 10:42am
tags:
Vanda, Illoperidone, Fanapt
Micromet: More Reasons for Optimism
Seeking Alpha
Monday, May 11, 2009 - 10:41am
tags:
Micromet, cancer, pipelines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.